Fundz

Propanc Biopharma Receives Investment from Institutional Investor

PUBLIC · PPCBJul 28, 2020

Round Type

Venture

AustraliaBiotechnologyHealthcare

Description

Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the company received an additional investment tranche from a lead institutional investor to support company operations and working capital needs. To date, a, total of $550,000 has been funded by the institutional investor of a $3,000,000 financing agreement, as the company prepares its lead product candidate, PRP, for a Phase IB, First-In-Human study, in advanced cancer patients suffering from solid tumors.

Quick answer

Propanc Biopharma raised an undisclosed amount in a funding round, dated July 28, 2020. Propanc Biopharma is based in Australia.

How much did Propanc Biopharma raise?
Propanc Biopharma raised an undisclosed amount in a funding round on July 28, 2020.
What does Propanc Biopharma do?
Propanc Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers.
Where is Propanc Biopharma based and how big is it?
Propanc Biopharma is based in Australia.
Who are the decision-makers at Propanc Biopharma?
Fundz holds 1 contact at Propanc Biopharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Propanc Biopharma that raised within 45 days of this round, from Fundz verified event records.

  • Metabolon raised $22M on September 11, 2020.
  • Monteris Medical raised $9M on September 4, 2020.
  • ORTHALIGN INC raised $11M on September 2, 2020.
  • Endovia Health Sciences, Inc. raised $1.2M on September 2, 2020.
  • Helaina Inc raised $4M (Seed) on August 31, 2020.
  • AEON Biopharma raised $25M on August 31, 2020.

Who to call at Propanc Biopharma, and when

A new round usually means Propanc Biopharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Propanc Biopharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Propanc Biopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Propanc Biopharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Propanc Biopharma

Location

302, 6 BUTLER STREET

Australia

About

Propanc Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. Together with our scientific and oncology consultants, we have developed a novel therapeutic approach based on 100 years of the scientific study of enzyme use. Our leading products not only treat metastatic cancer but reduce recurrence.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Propanc Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts11 people are listed at Propanc Biopharma. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Propanc Biopharma's next move

See what Strategic adds

Propanc Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.